Testing effectiveness (Phase 2)Study completedNCT01266083
What this trial is testing
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Sellas Life Sciences Group 22